Accuray Partners with University of Wisconsin to Enhance Cancer Care Through Innovative Radiotherapy Systems
On September 30, 2025, Accuray Incorporated, a leader in innovative radiation therapy solutions, announced a significant partnership with the University of Wisconsin School of Medicine and Public Health (UW SMPH). The two entities signed a Memorandum of Understanding (MOU) aimed at advancing online adaptive radiotherapy (OART) utilizing Accuray’s cutting-edge helical treatment delivery platform. This collaboration seeks to elevate the standard of cancer care by fostering a synergy of clinical research, education, and technology development.
The initiative stems from a mutual commitment to enhancing cancer treatment, particularly in the realm of personalized care. Mu Young Lee, Senior Vice President of Research and Product Development at Accuray, expressed enthusiasm regarding the partnership, emphasizing the shared objective of utilizing advanced radiation therapy technologies to improve patient survivorship and quality of life. He stated, “We believe OART can help to do just that, and we aim to reshape the overall experience for providers, making it feasible for clinical departments to adopt this advanced treatment option.”
The roots of this partnership can be traced back to the University of Wisconsin-Madison’s pioneering efforts in the field of radiation science. The university's researchers were behind the creation of the TomoTherapy® System, the first helical radiation delivery platform, which revolutionized radiation medicine. The system integrated 3D daily image guidance with intensity-modulated radiation therapy (IG-IMRT), raising precision and accuracy in cancer treatments. Accuray has built upon this foundation, continually refining the helical platform to enhance its capabilities further, including improvements in image quality and workflow efficiencies.
Nita Ahuja, MD, MBA, Dean of the School of Medicine and Vice Chancellor for Medical Affairs at UW-Madison, highlighted the importance of this collaboration and the focus on personalized, precision cancer care through OART. She noted, “This signifies our commitment to placing patients at the center of our research and medical advancements while providing essential training opportunities for future clinical researchers and physician-scientists.”
Accuray’s dedication to innovation in radiation therapy is evident in its approach to continuously evolve treatment solutions that cater to complex cases while simplifying the treatment process for more common cases. The company’s mission is to empower clinicians and healthcare providers, allowing them to support patients in returning to their lives quicker and with more effective treatment outcomes.
In addition to addressing the scientific aspects of the partnership, this collaboration also emphasizes the importance of educating the next generation of medical professionals. Through the exchange of knowledge and expertise between Accuray and UW-Madison, the initiative aims to cultivate a future workforce well-versed in the latest advancements in adaptive radiotherapy and personalized medicine.
As both organizations embark on this ambitious journey, they aim to bridge the gap between innovation and application in radiation therapy, ensuring that the advancements realized through research translate directly into improved patient care and treatment effectiveness. This partnership not only showcases the possibilities of combining academia with industry but also underscores the critical role that technology plays in advancing healthcare.
In summary, the partnership between Accuray and the University of Wisconsin-Madison marks a pivotal moment in advancing online adaptive radiotherapy. Together, they are poised to redefine the cancer care landscape, focusing on high-quality, personalized treatment options that can provide hope and improved outcomes for patients battling cancer.
For more information on Accuray and its innovative solutions, visit www.accuray.com. Additionally, information regarding the University of Wisconsin School of Medicine and Public Health can be found on their official website, showcasing their commitment to translating discovery into improved public health outcomes.
The initiative stems from a mutual commitment to enhancing cancer treatment, particularly in the realm of personalized care. Mu Young Lee, Senior Vice President of Research and Product Development at Accuray, expressed enthusiasm regarding the partnership, emphasizing the shared objective of utilizing advanced radiation therapy technologies to improve patient survivorship and quality of life. He stated, “We believe OART can help to do just that, and we aim to reshape the overall experience for providers, making it feasible for clinical departments to adopt this advanced treatment option.”
The roots of this partnership can be traced back to the University of Wisconsin-Madison’s pioneering efforts in the field of radiation science. The university's researchers were behind the creation of the TomoTherapy® System, the first helical radiation delivery platform, which revolutionized radiation medicine. The system integrated 3D daily image guidance with intensity-modulated radiation therapy (IG-IMRT), raising precision and accuracy in cancer treatments. Accuray has built upon this foundation, continually refining the helical platform to enhance its capabilities further, including improvements in image quality and workflow efficiencies.
Nita Ahuja, MD, MBA, Dean of the School of Medicine and Vice Chancellor for Medical Affairs at UW-Madison, highlighted the importance of this collaboration and the focus on personalized, precision cancer care through OART. She noted, “This signifies our commitment to placing patients at the center of our research and medical advancements while providing essential training opportunities for future clinical researchers and physician-scientists.”
Accuray’s dedication to innovation in radiation therapy is evident in its approach to continuously evolve treatment solutions that cater to complex cases while simplifying the treatment process for more common cases. The company’s mission is to empower clinicians and healthcare providers, allowing them to support patients in returning to their lives quicker and with more effective treatment outcomes.
In addition to addressing the scientific aspects of the partnership, this collaboration also emphasizes the importance of educating the next generation of medical professionals. Through the exchange of knowledge and expertise between Accuray and UW-Madison, the initiative aims to cultivate a future workforce well-versed in the latest advancements in adaptive radiotherapy and personalized medicine.
As both organizations embark on this ambitious journey, they aim to bridge the gap between innovation and application in radiation therapy, ensuring that the advancements realized through research translate directly into improved patient care and treatment effectiveness. This partnership not only showcases the possibilities of combining academia with industry but also underscores the critical role that technology plays in advancing healthcare.
In summary, the partnership between Accuray and the University of Wisconsin-Madison marks a pivotal moment in advancing online adaptive radiotherapy. Together, they are poised to redefine the cancer care landscape, focusing on high-quality, personalized treatment options that can provide hope and improved outcomes for patients battling cancer.
For more information on Accuray and its innovative solutions, visit www.accuray.com. Additionally, information regarding the University of Wisconsin School of Medicine and Public Health can be found on their official website, showcasing their commitment to translating discovery into improved public health outcomes.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.